Trials / Terminated
TerminatedNCT03866200
Resveratrol Trial for Relief of Pain in Pseudoachondroplasia
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine if self-administered oral resveratrol can dampen joint pain for individuals with pseudoachondroplasia compared to placebo. Another goal of this study is to evaluate side effects in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | resveratrol | 125 mg/day or 5 ml once per day for 90 days |
| DRUG | Placebo | 5 ml once per day for 90 days |
Timeline
- Start date
- 2019-06-29
- Primary completion
- 2020-10-28
- Completion
- 2020-10-28
- First posted
- 2019-03-07
- Last updated
- 2022-12-09
- Results posted
- 2022-12-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03866200. Inclusion in this directory is not an endorsement.